Inventor

JUNE CARL

US11 patents

⚠️ This page may combine multiple inventors who share the name “JUNE CARL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PENNSYLVANIA

5 patents

US7745140B2Jun 29, 2010

Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool

UNIV PENNSYLVANIA85 citations96

US7638326B2Dec 29, 2009

Activation and expansion of T-cells using an engineered multivalent signaling platform

UNIV PENNSYLVANIA68 citations96

US7638325B2Dec 29, 2009

Activation and expansion of T-cells using an engineered multivalent signaling platform

UNIV PENNSYLVANIA35 citations91

US7670781B2Mar 2, 2010

Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal

UNIV PENNSYLVANIA11 citations83

US7651855B2Jan 26, 2010

Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

UNIV PENNSYLVANIA11 citations82

GODFREY WAYNE R

2 patents

US9187727B2Nov 17, 2015

Methods for the isolation and expansion of cord blood derived T regulatory cells

GODFREY WAYNE R5 citations68

US9273282B2Mar 1, 2016

Methods for the isolation and expansion of cord blood derived T regulatory cells

GODFREY WAYNE R2 citations58

BLAZAR BRUCE

2 patents

US9181526B2Nov 10, 2015

Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

BLAZAR BRUCE2 citations59

US8129185B2Mar 6, 2012

Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

BLAZAR BRUCE3 citations59

US GOV HEALTH & HUMAN SERV

1 patent

US7718196B2May 18, 2010

Rapamycin-resistant T cells and therapeutic uses thereof

US GOV HEALTH & HUMAN SERV3 citations58

FOWLER DANIEL H

1 patent

US8075921B2Dec 13, 2011

Rapamycin-resistant T cells and therapeutic uses thereof

FOWLER DANIEL H1 citations41